Sort   by:  
 Page size 
ProteomicsGeneration of zero-valent sulfur from dissimilatory sulfate reduction in sulfate-reducing microorganisms
Dissimilatory sulfate reduction (DSR) mediated by sulfate-reducing microorganisms (SRMs) plays a pivotal role in global sulfur, carbon, oxygen, and iron cycles since ~3.5 billion years ago. The canonical DSR pathway is believed to be sulfate reduction to sulfide. Herein, we report a new DSR pathway ...
ORGANISM(S): Desulfovibrio vulgaris str. Hildenborough 
2023-04-28 | PXD040825 | Pride
Sulfate-reducing microorganisms desulfovibrio vulgaris hildenborough 
UnknownElectroacupuncture stimulating Zusanli (ST36), Sanyinjiao (SP6) in mice with collagen-induced arthritis leads to adenosine A2A receptor-mediated alteration of p38α mitogen-activated protein kinase signaling and inhibition of osteoclastogenesis.
Not available
S-EPMC10623259 | biostudies-literature
ProteomicsThe NAE1-mediated Neddylation operates as an essential post-translational modification checkpoint for effector CD8+ T cells
Cells were lysed with TFA, and precipitated with cold acetone. The precipitates were transferred to E3filters and digestion was performed overnight with trypsin. The peptides were desalted with StageTips, and were analyzed on Eclipse Orbitrap with DIA mode. For MS1, the resolution was set to 120,00...
ORGANISM(S): Mus Musculus (ncbitaxon:10090) 
2024-02-27 | MSV000094179 | MassIVE
ProteomicsGenetic origin and evolution of bioluminescence of fireflies
provide new perspectives and important resources for further exploring bioluminescence origin and evolution in insects
ORGANISM(S): Lamprigera Yunnana 
PXD015226 |
ProteomicsThe origin and evolution of bioluminescence of fireflies
provide new perspectives and important resources for further exploring bioluminescence origin and evolution in insects
ORGANISM(S): Luciola Terminalis 
PXD015227 |
ProteomicsBCAT1 Confers Resistance to EGFR TKIs through α-KG-dependent Epigenetic Regulation of the Glycolysis Pathway in NSCLC
Epidermal growth factor receptor (EGFR) mutations are leading oncogenic drivers in non-small cell lung cancer (NSCLC). Many third-generation EGFR tyrosine kinase inhibitors (TKIs) have been developed to target EGFR T790M and activating mutations. Osimertinib (AZD9291) was the first approved drug and...
ORGANISM(S): Homo Sapiens 
PXD043776 |
Sort   by:  
 Page size